Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000867346 | SCV001008559 | likely benign | not provided | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002495272 | SCV002794666 | likely benign | Medulloblastoma; Familial dysautonomia | 2021-10-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004027696 | SCV003907092 | likely benign | not specified | 2023-02-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001274634 | SCV001458968 | likely benign | Familial dysautonomia | 2020-09-16 | no assertion criteria provided | clinical testing |